Medtronic's (MDT) IDE for SLATE Study Receives FDA Approval

June 17, 2016 9:06 AM EDT Send to a Friend
Medtronic plc (NYSE: MDT) announced the U.S. Food and Drug Administration's (FDA) approval of the Investigational Device Exemption (IDE) application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login